Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Your RPS

Pharmacist brought in to encourage BAME recruitment to major UK COVID-19 clinical trial

Mahendra Patel, a member of the Royal Pharmaceutical Society’s English Pharmacy Board, has joined the PRINCIPLE trial as its national black, Asian and minority ethnic community and pharmacy lead.

Open access article

The Royal Pharmaceutical Society has made this article free to access in order to help healthcare professionals stay informed about an issue of national importance.

To learn more about coronavirus, please visit: https://www.rpharms.com/resources/pharmacy-guides/wuhan-novel-coronavirus

Mahendra Patel

Source: Nic Bunce / The Pharmaceutical Journal

Mahendra Patel will work to widen access to the University of Oxford’s PRINCIPLE trial

A pharmacist has been hired to strengthen recruitment of black, Asian and minority ethnic (BAME) patients to one of the major UK-based COVID-19 trials.

Mahendra Patel, a member of the Royal Pharmaceutical Society’s (RPS’s) English Pharmacy Board, has joined the PRINCIPLE trial as its national BAME community and pharmacy lead.

The national trial, led by the University of Oxford, aims to find treatments for COVID-19 that are suitable for patients aged over 50, and that can be taken at home and therefore reduce the need for patients to go to hospital.

To date, more than 850 people have volunteered to take part in the trial. However, in a statement published on 18 September 2020, the university said that “recruiting people from black, Asian and minority ethnic communities has been a particular challenge”, even though people from these communities may be at higher risk of becoming seriously ill as a result of COVID-19.

In his new role, Patel will work to widen access to the PRINCIPLE trial among people from BAME communities.

“There has to be a more concerted and tailored effort to reach out to black, Asian and minority ethnic communities more effectively in health research — particularly in the case of COVID-19, where we are seeing members of these communities unfortunately experiencing a greater risk of contracting the virus with higher adverse effects and even deaths,” he said.

Patel added that “pharmacists play a valuable role in the community and in primary care, and there is an opportunity here to use those channels more effectively in recruiting people from all backgrounds into this trial”.

Chris Butler, lead investigator at University of Oxford’s Nuffield Department of Primary Care Health Sciences, said that “conventional patient recruitment strategies, which rely on utilising established national and regional clinical networks, often fail to reach those who are typically under-represented in health research”. He added that a “more targeted and culturally sensitive approach is crucial for researchers seeking to understand more about COVID-19 and how to treat it”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2020.20208372

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.